Trial intelligence / Profile preview

Loperamide Plus Azithromycin for Travelers' Diarrhea

NCT00359970Phase 4Completed

Sponsor
UTHealth Houston
Start
Jun 2002
Primary completion
Aug 2003
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of loperamide in traveler's diarrhea (TD) (3 arms), sponsored by UTHealth Houston. Primary endpoint: Hours from beginning treatment to passage of last unformed stool at 4 days. Started Jun 2002; status: completed.

02

Drugs

loperamide
03

Conditions

traveler's diarrhea (TD)

Beyond the preview

Go deeper on NCT00359970.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00359970.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call